Congo vs Honduras: The number of people with susceptibility test result for rifampicin
Congo
42.71
in 2021
Honduras
42.38
in 2021
Congo rank
122nd
Honduras rank
123rd
The number of people with susceptibility test result for rifampicin over time
- Congo
- Honduras
How they compare
Congo currently reports 42.71 against 42.38 in Honduras, a difference of 0.33.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Honduras ahead.
Congo ranks 122nd and Honduras ranks 123rd of 146 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Honduras in 1.
Head to head by decade
| Decade | Congo | Honduras | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.4 | 44.47 | 29.08 | Honduras |
| 2020s | 71.35 | 50.77 | 20.59 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo or Honduras?
- Congo, at 42.71 against 42.38 in Honduras as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo and Honduras?
- 0.33, with Congo ahead.
- How many years of comparable data are there for Congo and Honduras?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo and Honduras rank globally for the number of people with susceptibility test result for rifampicin?
- Congo ranks 122nd and Honduras ranks 123rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.